Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals Read more about Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
20th Annual Amgen Award For Science Teaching Excellence Honors Nine Outstanding Teachers Read more about 20th Annual Amgen Award For Science Teaching Excellence Honors Nine Outstanding Teachers
Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE(TM) Trial Read more about Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE(TM) Trial
Amgen Announces Voting Results of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results of Annual Meeting of Stockholders
Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate Of Complete Response In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia Read more about Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate Of Complete Response In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer Read more about Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars Read more about Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Cancer Support Community Launches National Program to Assist Patients With Cancer, Make Informed Decisions About Care Read more about Cancer Support Community Launches National Program to Assist Patients With Cancer, Make Informed Decisions About Care
CURE Magazine Announces Winner of the 2012 Extraordinary Healer Award for Oncology Nursing Read more about CURE Magazine Announces Winner of the 2012 Extraordinary Healer Award for Oncology Nursing
Amgen to Present at the Baird Growth Stock Conference Read more about Amgen to Present at the Baird Growth Stock Conference
